Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up

Gastroenterology Report
Chao DingNing Li

Abstract

Gut microbiota may contribute to regulate colonic motility, which is involved in the etiology of constipation. Fecal microbiota transplantation (FMT) has been demonstrated to restore intestinal homeostasis. The aim of this study was to evaluate the clinical outcomes and prognostic factors of FMT for the treatment of slow transit constipation (STC). Fifty-two patients with STC received standardized FMT and were followed up for 6 months. Bowel habit, colonic transit time, constipation-related symptoms (PAC-SYM score), quality of life (PAC-QOL score), treatment satisfaction scores and adverse events were monitored. The primary efficacy endpoint was the proportion of patients having on average three or more complete spontaneous bowel movements (CSBMs) per week. The primary efficacy endpoint was achieved in 50.0%, 38.5% and 32.7% of patients over week intervals 3-4, 9-12 and 21-24, respectively (P < 0.01 for all comparisons). Significant improvements were also observed in other bowel movement assessments, colonic transit time, constipation-related symptoms and quality of life; but all improvements diminished at weeks 12 and 24. Incompleteness of evacuation served as the only factor associated with efficacy. No serious treatment-rela...Continue Reading

References

Oct 16, 1999·Scandinavian Journal of Gastroenterology·L FrankP Miner
Aug 23, 2002·The American Journal of Gastroenterology·E J IrvineL Rance
Oct 3, 2003·The New England Journal of Medicine·Anthony Lembo, Michael Camilleri
May 18, 2005·PharmacoEconomics·Cheryl DennisonKarin Coyne
Jul 23, 2005·Scandinavian Journal of Gastroenterology·Patrick MarquisOlivier Chassany
May 9, 2006·Gastroenterology·Douglas A Drossman
Feb 20, 2007·Alimentary Pharmacology & Therapeutics·J F Johanson, J Kralstein
May 30, 2008·The New England Journal of Medicine·Michael CamilleriLieve Vandeplassche
Dec 3, 2009·The American Journal of Gastroenterology·Ashok AttaluriSatish S C Rao
Feb 1, 2012·The American Journal of Gastroenterology·Matthew J HamiltonAlexander Khoruts
Dec 25, 2012·Gastroenterology·Adil E BharuchaAmanda Pressman
Dec 25, 2012·Gastroenterology·Adil E BharuchaG Richard Locke
Feb 6, 2013·Gastroenterology·Purna C KashyapJustin L Sonnenburg
Sep 26, 2013·The American Journal of Gastroenterology·Sieglinde AngelbergerDavid Berry
Nov 19, 2013·Cell Host & Microbe·Anita WichmannFredrik Bäckhed
Apr 16, 2014·The American Journal of Gastroenterology·Anton EmmanuelRené Kerstens
Jul 31, 2014·Physiological Genomics·Lixin ZhuSusan S Baker
Oct 17, 2014·JAMA : the Journal of the American Medical Association·Ilan YoungsterElizabeth L Hohmann
Nov 27, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D M PinnL J Brandt
Aug 16, 2015·Gut·E F TigchelaarA Zhernakova
Jan 12, 2016·Journal of Clinical Gastroenterology·Hongliang TianNing Li
May 20, 2016·Gut·Fatemeh HadizadehMauro D'Amato

❮ Previous
Next ❯

Citations

Dec 13, 2018·Journal of Pediatric Gastroenterology and Nutrition·Zev H DavidovicsUNKNOWN FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European S
Aug 29, 2019·Physiological Reviews·John F CryanTimothy G Dinan
Nov 23, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Jordi SerraUNKNOWN Functional Constipation Guidelines Working Group
Nov 26, 2019·The American Journal of Gastroenterology·Adeyinka Charles AdejumoKyle Staller
Jun 7, 2019·Current Opinion in Pediatrics·Bhaskar Gurram, Paul K Sue
Nov 7, 2019·Nature Reviews. Gastroenterology & Hepatology·Mana H VriesmanMarc A Benninga
Feb 6, 2019·Frontiers in Cellular and Infection Microbiology·Brooke C WilsonJustin M O'Sullivan
Feb 28, 2019·Frontiers in Medicine·Toshifumi OhkusaNobuhiro Sato
Jun 27, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Zhenyuan XuZhongshan Yang
Jun 16, 2019·EBioMedicine·Koen WortelboerHilde Herrema
Jan 12, 2021·Neurobiology of Pain·Courtney A BannermanNader Ghasemlou
Nov 17, 2020·Journal of Paediatrics and Child Health·Rishi BoliaMark R Oliver
Nov 13, 2020·European Journal of Gastroenterology & Hepatology·Aravind Gokul Tamilarasan, Thanuja Krishnananthan
Dec 31, 2020·Journal of Clinical Nursing·Jessica GuilfoyleStéphane L Bouchoucha
Mar 2, 2021·World Journal of Gastroenterology : WJG·Ya-Mei ZhengLi-Hao Wu
Jun 4, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Monica GulatiLipika Chandwani
May 1, 2021·Journal of Clinical Medicine·Jakub WłodarczykMarcin Włodarczyk

❮ Previous
Next ❯

Methods Mentioned

BETA
cesarean section
lavage
X-ray

Clinical Trials Mentioned

NCT02301221
NCT02526849

Related Concepts

Related Feeds

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.